MX2007016151A - Composiciones de liberacion controlada y en forma de nano-particulas que comprenden compuestos aril-heterociclicos. - Google Patents

Composiciones de liberacion controlada y en forma de nano-particulas que comprenden compuestos aril-heterociclicos.

Info

Publication number
MX2007016151A
MX2007016151A MX2007016151A MX2007016151A MX2007016151A MX 2007016151 A MX2007016151 A MX 2007016151A MX 2007016151 A MX2007016151 A MX 2007016151A MX 2007016151 A MX2007016151 A MX 2007016151A MX 2007016151 A MX2007016151 A MX 2007016151A
Authority
MX
Mexico
Prior art keywords
less
composition according
ziprasidone
composition
particles
Prior art date
Application number
MX2007016151A
Other languages
English (en)
Spanish (es)
Inventor
John Devane
Paul Stark
Scott Jenkins
Gary Liversidge
Niall Fanning
Gurvinder Rekhi
Original Assignee
Elan Pharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/372,857 external-priority patent/US20060240105A1/en
Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd
Priority claimed from PCT/US2006/023695 external-priority patent/WO2007027273A1/en
Publication of MX2007016151A publication Critical patent/MX2007016151A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007016151A 2005-06-20 2006-06-19 Composiciones de liberacion controlada y en forma de nano-particulas que comprenden compuestos aril-heterociclicos. MX2007016151A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69209605P 2005-06-20 2005-06-20
US11/372,857 US20060240105A1 (en) 1998-11-02 2006-03-10 Multiparticulate modified release composition
PCT/US2006/023695 WO2007027273A1 (en) 2005-06-20 2006-06-19 Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds

Publications (1)

Publication Number Publication Date
MX2007016151A true MX2007016151A (es) 2008-03-06

Family

ID=39933852

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007016151A MX2007016151A (es) 2005-06-20 2006-06-19 Composiciones de liberacion controlada y en forma de nano-particulas que comprenden compuestos aril-heterociclicos.

Country Status (4)

Country Link
JP (1) JP2008546781A (enExample)
CN (1) CN101242813A (enExample)
MX (1) MX2007016151A (enExample)
ZA (1) ZA200710715B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8951996B2 (en) * 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
MX2017007054A (es) * 2014-12-03 2018-05-02 Velicept Therapeutics Inc Composiciones y métodos para usar solabegron de liberación modificada para sintomas del tracto urinario inferior.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
KR20060115350A (ko) * 2003-09-02 2006-11-08 화이자 프로덕츠 인크. 지프라시돈의 지속 방출형 투여 형태
CA2605153A1 (en) * 2005-04-13 2006-10-19 Jaymin Chandrakant Shah Injectable depot formulations and methods for providing sustained release of nanoparticle compositions

Also Published As

Publication number Publication date
JP2008546781A (ja) 2008-12-25
ZA200710715B (en) 2009-03-25
CN101242813A (zh) 2008-08-13

Similar Documents

Publication Publication Date Title
US8119163B2 (en) Nanoparticulate and controlled release compositions comprising cefditoren
AU2007260822B2 (en) Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
AU2007202941A1 (en) Nanoparticulate and controlled release compositions comprising cephalosporin
JP2009541359A (ja) ナノ粒子状ナプロキセンおよび制御放出ヒドロコドンを含む組成物
US20080317843A1 (en) Nanoparticulate formulations of modafinil
US20090297596A1 (en) Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor
MX2007014363A (es) Composiciones de liberacion controlada y en forma de nanoparticulas que comprenden una cefalosporina.
CN101879140A (zh) 包含芳基-杂环化合物的毫微粒和控制释放组合物
WO2008073068A1 (en) Nanoparticulate and controlled release compositions comprising cefditoren
WO2007070082A1 (en) Nanoparticulate and controlled release compositions comprising teprenone
AU2006343445B2 (en) Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
US20100247636A1 (en) Nanoparticulate and controlled release compositions comprising nilvadipine
JP2008546781A (ja) アリール−複素環式化合物を含んでなるナノ粒状及び制御放出の組成物
MX2007014764A (en) Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
WO2007106111A2 (en) Nanoparticulate and controlled release compositions comprising nilvadipine
HK1117415A (en) Nanoparticulate and controlled release compositions comprising a cephalosporin

Legal Events

Date Code Title Description
FA Abandonment or withdrawal